TI
AEON icon

Tidal Investments’s AEON Biopharma AEON Stock Holding History

Tidal Investments’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-342
Closed -$248K – 1304
2022
Q4 		$248K Hold
342
– – 0.01% 960
2022
Q3 		$243K Hold
342
– – 0.01% 868
2022
Q2 		$241K Buy
342
+42
+14% +$29.6K 0.01% 904
2022
Q1 		$211K Hold
300
– – 0.01% 990
2021
Q4 		$210K Buy
300
+155
+107% +$109K 0.01% 902
2021
Q3 		$101K Buy
+145
New +$101K ﹤0.01% 839

Other funds holding AEON

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
GCWM
Graham Capital Wealth Management Washington D.c., District of Columbia $113M AUM 11.26% 1-Year Est. Return

Tidal Investments's AEON Position: Q1 2023 in Review

Tidal Investments sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 342 shares — an estimated $248K sold.

Tidal Investments first reported a position in AEON in Q3 2021 and held it in 6 quarters. The position peaked at $248K in Q4 2022. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.

  • Tidal Investments reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
  • Tidal Investments sold 342 AEON Biopharma shares in Q1 2023, an estimated $248K.
  • Tidal Investments first reported a position in AEON Biopharma in Q3 2021 and held it in 6 quarters.
  • Tidal Investments's AEON Biopharma position peaked at $248K in Q4 2022.
  • 21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.

Based on Tidal Investments's 13F filing for Q1 2023, filed 15 May 2023.